Bioporto A/S
CSE:BIOPOR
Bioporto A/S
Other
Bioporto A/S
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioporto A/S
CSE:BIOPOR
|
Other
-kr3.4m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Other
-kr109m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-15%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Other
-kr236.6m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Other
-€19.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Other
-kr174k
|
CAGR 3-Years
81%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Saniona AB
STO:SANION
|
Other
-kr9.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bioporto A/S
Glance View
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.
See Also
What is Bioporto A/S's Other?
Other
-3.4m
DKK
Based on the financial report for Sep 30, 2024, Bioporto A/S's Other amounts to -3.4m DKK.
What is Bioporto A/S's Other growth rate?
Other CAGR 5Y
-21%
Over the last year, the Other growth was -110%. The average annual Other growth rates for Bioporto A/S have been 38% over the past three years , -21% over the past five years .
You don't have any saved screeners yet